InSphero at the MASH Pathogenesis and Therapeutic Approaches 2025
Join us at the MASH Pathogenesis and Therapeutic Approaches 2025 in Banff, Canada.
Quick navigation
Meet our Team at the MASH Pathogenesis and Therapeutic Approaches 2025
Francisco Verdeguer, PhD
Vice President, Liver Disease
Francisco Verdeguer, PhD
Vice President, Liver Disease
Francisco has been the VP of Liver Discovery at InSphero since 2021. He obtained a PhD in molecular biology at the Pasteur Institute in Paris. He has been trained for 6 years as a postdoctoral fellow at Harvard University/Dana Farber Cancer Institute and Karolinska Institute where he focused on the molecular basis of metabolic disorders. He was appointed Assistant Professor at the University of Zurich between 2016 and 2021 where he led a basic research group and has identified novel mechanisms of energy balance regulation.
Sue Grepper, PhD
Director of Business Development
Sue Grepper, PhD
Director of Business Development
Sue is an experienced scientist with over 20 years of in vitro research experience. Sue holds a PhD in Pharmacology/Toxicology from the University of Arizona. She has dedicated the majority of her career to helping scientists achieve their research goals with human cell-based models.
Short Talk at the MASH Pathogenesis and Therapeutic Approaches 2025
Multiparametric Screening of MASH Clinical Candidates In Human Liver Spheroids Predicts Clinical Outcomes And Reveals Potential Novel Combinations For Anti-Steatotic And Anti-Fibrotic Therapies
Date: Tuesday, 25 February, 2025 | 5:00 - 7:00 PM
Location: Van Horne B
Francisco Verdeguer, PhD
Vice President, Liver Disease
Francisco Verdeguer, PhD
Vice President, Liver Disease
Francisco has been the VP of Liver Discovery at InSphero since 2021. He obtained a PhD in molecular biology at the Pasteur Institute in Paris. He has been trained for 6 years as a postdoctoral fellow at Harvard University/Dana Farber Cancer Institute and Karolinska Institute where he focused on the molecular basis of metabolic disorders. He was appointed Assistant Professor at the University of Zurich between 2016 and 2021 where he led a basic research group and has identified novel mechanisms of energy balance regulation.
The MASH CALL Initiative for Fast & Reliable Compound Identification
Join by February 28 and Unlock the Full Potential of your Research
Select and compare the best anti-steatotic and anti-fibrotic drug candidates and follow-up with a comprehensive phenotypic analysis
